首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1746880

日本細胞治療市場報告（按細胞類型、治療類型、治療領域、最終用戶和地區）2025-2033

Japan Cell Therapy Market Report by Cell Type, Therapy Type, Therapeutic Area, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 116 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本細胞治療市場規模達3.77億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到17.636億美元，2025-2033年期間的複合年成長率（CAGR）為17.77%。推動市場發展的因素包括患者知識水準的提高、政府支持力度的增加以及保險覆蓋範圍的擴大。

細胞療法 (CT) 是指將人類細胞移植到受損的組織和細胞上，從而治療各種疾病。這種綜合療法涵蓋多種類型的細胞，例如造血幹細胞 (HSC)、骨骼肌幹細胞、間質幹細胞、淋巴細胞、樹突狀細胞和胰島細胞。其應用範圍不僅限於增強免疫系統以治療癌症，還涵蓋自體免疫疾病、感染性疾病、泌尿系統疾病、關節軟骨損傷、脊髓損傷、免疫系統受損以及神經系統疾病的治療。細胞療法在再生藥物的生產中發揮著至關重要的作用，促進了旨在修復組織和器官以及恢復因衰老、疾病或損傷而受到影響的功能的創新療法的研發和實施。

日本細胞治療市場趨勢：

日本細胞療法市場主要受生物技術快速發展的刺激。同時，研發投入的顯著增加也對市場成長起到了至關重要的作用。此外，來自政府和私人投資者的資金投入也進一步推動了細胞療法的研究和商業化。此外，臨床試驗活動的擴展有助於驗證細胞療法的有效性和安全性，從而加速市場擴張。慢性疾病和退化性疾病的日益普及催生了對先進治療方案的需求，從而推動了市場的發展。隨著人口老化，針對年齡相關疾病的再生療法的需求日益成長，從而增強了市場競爭力。此外，針對個別患者的個人化細胞療法日益普及，也促進了市場的成長。監管機構也正在為細胞療法的核准提供更清晰的途徑，為市場帶來積極的前景。競爭格局推動著細胞治療產品的創新和多樣化，而罕見疾病發病率的上升進一步推動了市場的上升趨勢。

日本細胞治療市場細分：

細胞類型洞察：

幹細胞
- 骨髓
- 血
- 臍帶來源
- 脂肪幹細胞
- 其他
非幹細胞

治療類型見解：

自體
同種異體

治療領域洞察：

惡性腫瘤
肌肉骨骼疾病
自體免疫疾病
皮膚科
其他

最終用戶洞察：

醫院和診所
學術和研究機構

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本細胞治療市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本細胞治療市場有何影響？
根據細胞類型，日本細胞治療市場是如何分類的？
根據治療類型，日本細胞治療市場是如何分類的？
日本細胞治療市場依治療領域分類是怎樣的？
根據最終用戶，日本細胞治療市場是如何分類的？
日本細胞治療市場的價值鏈分為哪些階段？
日本細胞療法的主要促進因素和挑戰是什麼？
日本細胞治療市場的結構是怎麼樣的？主要參與者是誰？
日本細胞治療市場的競爭程度如何？

本報告回答的關鍵問題：

日本細胞治療市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本細胞治療市場有何影響？
根據細胞類型，日本細胞治療市場是如何分類的？
根據治療類型，日本細胞治療市場是如何分類的？
日本細胞治療市場依治療領域分類是怎樣的？
根據最終用戶，日本細胞治療市場是如何分類的？
日本細胞治療市場的價值鏈分為哪些階段？
日本細胞療法的主要促進因素和挑戰是什麼？
日本細胞治療市場的結構是怎麼樣的？主要參與者是誰？
日本細胞治療市場的競爭程度如何？

Japan cell therapy market size reached USD 377.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,763.6 Million by 2033, exhibiting a growth rate (CAGR) of 17.77% during 2025-2033. Some of the factors driving the market include the increasing knowledge among patients, the rising backing from the government, and the widening scope of insurance coverage.

Cell therapy (CT) involves the transfer of human cells to address damage to tissues and cells, offering remedies for various medical conditions. This comprehensive approach includes various types of cells such as hematopoietic stem cells (HSC), skeletal muscle and mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. Its applications go beyond strengthening the immune system for cancer treatment and also encompass the treatment of autoimmune and infectious diseases, urinary issues, joint cartilage damage, spinal cord injuries, compromised immune systems, and neurological disorders. It plays a crucial role in the production of regenerative medicines, facilitating the creation and implementation of innovative treatments aimed at the restoration of tissues and organs and the recovery of functions affected by aging, diseases, or injuries.

Japan Cell Therapy Market Trends:

The Japan cell therapy market is primarily stimulated by the rapid progressions in biotechnology. This development is complemented by a notable increase in research and development endeavors, which are playing a significant role in the market's growth. Additionally, the influx of funding from both governmental sources and private investors is further fueling the research and commercialization of cell therapy. Furthermore, the expansion of clinical trial activities serves to authenticate the effectiveness and safety of cell therapies, thereby accelerating market expansion. The escalating prevalence of chronic and degenerative diseases is creating a demand for advanced treatment options, consequently propelling the market forward. With an aging population, there is a growing necessity for regenerative therapies tailored to age-related conditions, thus fortifying the market. Moreover, the increasing popularity of personalized cell therapies tailored to individual patients is fostering the growth of the market. Regulatory agencies are also providing clearer pathways for the approval of cell therapy, fostering a positive outlook for the market. The competitive landscape is driving innovation and diversification of cell therapy products, while the escalating incidence of rare diseases is further contributing to the market's upward trajectory.

Japan Cell Therapy Market Segmentation:

Cell Type Insights:

Stem Cell
- Bone Marrow
- Blood
- Umbilical Cord-Derived
- Adipose-Derived Stem Cell
- Others
Non-stem Cell

Therapy Type Insights:

Autologous
Allogeneic

Therapeutic Area Insights:

Malignancies
Musculoskeletal Disorders
Autoimmune Disorders
Dermatology
Others

End User Insights:

Hospitals and Clinics
Academic and Research Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan cell therapy market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan cell therapy market?
What is the breakup of the Japan cell therapy market on the basis of cell type?
What is the breakup of the Japan cell therapy market on the basis of therapy type?
What is the breakup of the Japan cell therapy market on the basis of therapeutic area?
What is the breakup of the Japan cell therapy market on the basis of end user?
What are the various stages in the value chain of the Japan cell therapy market?
What are the key driving factors and challenges in the Japan cell therapy?
What is the structure of the Japan cell therapy market and who are the key players?
What is the degree of competition in the Japan cell therapy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Cell Therapy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Cell Therapy Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Cell Therapy Market - Breakup by Cell Type

6.1 Stem Cell
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Bone Marrow
  - 6.1.3.2 Blood
  - 6.1.3.3 Umbilical Cord-Derived
  - 6.1.3.4 Adipose-Derived Stem Cell
  - 6.1.3.5 Others
- 6.1.4 Market Forecast (2025-2033)
6.2 Non-stem Cell
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Cell Therapy Market - Breakup by Therapy Type

7.1 Autologous
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Allogeneic
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Cell Therapy Market - Breakup by Therapeutic Area

8.1 Malignancies
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Musculoskeletal Disorders
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Autoimmune Disorders
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Dermatology
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2019-2024)
- 8.4.3 Market Forecast (2025-2033)
8.5 Others
- 8.5.1 Historical and Current Market Trends (2019-2024)
- 8.5.2 Market Forecast (2025-2033)

9 Japan Cell Therapy Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)

10 Japan Cell Therapy Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Cell Therapy Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis